Seeing Market Shift, Invitrogen to Exclusively Distribute Blue Heron's Synthetic Gene Products | GenomeWeb
NEW YORK (GenomeWeb News) — Invitrogen, saying it sees more researchers moving toward using synthetic genes over clones, today said it will exclusively distribute Blue Heron's synthetic gene products.
Through the agreement, Invitrogen said it will make an undisclosed investment in Blue Heron in exchange for exclusive worldwide distribution rights for the firm’s GeneMaker platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.